Quantcast
Last updated on April 20, 2014 at 8:07 EDT

Latest Insulin aspart Stories

2014-03-10 23:04:30

ChinaMarketResearchReports.com adds Latest Reports on China Insulin Aspart & Lispro Market to its store. Dallas, TX (PRWEB) March 10, 2014 According to IDF (the International Diabetes Federation), incidence of diabetes among adults aged 20-79 in the world was 8.3% in 2013 with more than 380 million patients worldwide. On December 26, 2001 Novo Nordisk announced that the first insulin analogue insulin aspart (marketed by Novo Nordisk with the trade name "Novorapid") to treat...

2013-12-02 20:22:24

COPENHAGEN, Denmark, December 2, 2013 /PRNewswire/ -- Data presented today at the World Diabetes Congress of the International Diabetes Federation (IDF) show that adults with type 2 diabetes achieved improved glycaemic control, significantly lower rates of overall and nocturnal confirmed hypoglycaemia for the full trial period, and a significantly lower rate of severe hypoglycaemia during the maintenance period (defined as week 16 onwards) with Ryzodeg(R) compared to biphasic...

2013-11-01 16:23:33

( ) PLAINSBORO, N.J., Nov. 1, 2013 /PRNewswire/ -- Novo Nordisk, a world leader in diabetes care, today announced that the U.S. Food and Drug Administration (FDA) has approved the prefilled insulin pens NovoLog(®) (insulin aspart [rDNA origin] injection) FlexTouch(®) and Levemir(®) (insulin detemir [rDNA origin] injection) FlexTouch(®). FlexTouch(®) is a new prefilled insulin delivery system from Novo Nordisk. To view the multimedia assets associated with this release, please click:...

2013-11-01 08:27:52

Contest raises $35,000 in donations to local diabetes-related organizations PLAINSBORO, N.J, Nov. 1, 2013 /PRNewswire/ -- Novo Nordisk, a world leader in diabetes care, announced today that Walton Kelly from Thomaston, Georgia, is the grand prize winner of the NovoLog® Community Star contest. The contest was held earlier this year to recognize patients with type 2 diabetes who use NovoLog® (insulin aspart [rDNA origin] injection) to help manage their blood sugar and give back to their local...

2013-10-18 12:24:20

MISSISSAUGA, ON, Oct. 18, 2013 /CNW/ - Novo Nordisk today announced that Health Canada has approved Levemir((R)) FlexTouch((R)), a disposable prefilled insulin pen containing Levemir((R)) (insulin detemir). Levemir((R)) FlexTouch((R)) has been designed to improve ease of use for insulin administration and to help decrease barriers to good treatment adherence for Canadians living with type 1 and type 2 diabetes mellitus (diabetes). The approval was also announced at the 2013...

2013-08-21 12:27:19

First insulin injection device to combine half-unit dosing with a memory function to help patients better manage their diabetes PLAINSBORO, N.J., Aug. 21, 2013 /PRNewswire/ -- Novo Nordisk, a world leader in diabetes care, announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the insulin device NovoPen Echo(®). This marks the first and only pen device in the U.S. with half-unit dosing and a memory function that records the dose and time passed...

Inhaled Insulin More Effective Than Injected, Oral Treatments
2013-08-15 05:18:19

redOrbit Staff & Wire Reports - Your Universe Online MannKind Corp. announced on Wednesday its inhaled insulin device was shown to be more effective than injected and oral treatments in two late-stage clinical trials. The product, known as Afrezza, consists of a fast-acting insulin powder delivered via MannKind’s lightweight inhaler. Administered at the start of a meal, Afrezza dissolves immediately upon inhalation and delivers insulin quickly to the blood stream. Peak insulin...

2013-08-06 08:21:25

Charlie Kimball Makes History as First Driver with Diabetes to Win an IndyCar Race PLAINSBORO, N.J., Aug. 6, 2013 /PRNewswire/ -- Novo Nordisk, a world leader in diabetes care, is pleased to announce that Charlie Kimball, driver of the No. 83 NovoLog(®) FlexPen(®) Honda, has become the first and only licensed driver with diabetes to win an IndyCar race. This milestone was achieved as the Novo Nordisk Chip Ganassi Racing Team saw its first-ever IndyCar Series victory, secured at the...

2013-06-24 12:25:44

CHICAGO, June 24, 2013 /PRNewswire/ -- Patients with type 2 diabetes, who are inadequately controlled on basal insulin plus oral anti-diabetic medications (OADs), obtained comparable reduction in A1c, whether they intensified with bolus insulin treatment step by step, or followed a full basal-bolus treatment with every meal from the start. Novo Nordisk presented data from the Full STEP(TM) study today at the 73(rd) Scientific Sessions of the American Diabetes Association (ADA)....

2013-04-05 08:23:44

Enter today for a chance to win a trip to the 2013 IndyCar® Series finale BIRMINGHAM, Ala., April 5, 2013 /PRNewswire/ -- Novo Nordisk, a world leader in diabetes care, and IZOD IndyCar Series driver Charlie Kimball today kicked off a new contest asking people to support Charlie by encouraging their friends and family to join the Race with Insulin(®) crew. Now through September 15, by sharing Kimball's story about the importance of team support with two or more friends or...